Agilent Technologies, Inc. (NYSE:A) Receives $163.31 Average Price Target from Analysts

Shares of Agilent Technologies, Inc. (NYSE:A) have been assigned a consensus rating of “Moderate Buy” from the eighteen research firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $164.50.

A number of analysts have recently commented on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. UBS Group raised their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Evercore ISI raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Bank of America raised their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th.

Agilent Technologies Price Performance

A stock opened at $134.90 on Monday. The stock has a market cap of $38.25 billion, a price-to-earnings ratio of 29.52, a P/E/G ratio of 4.02 and a beta of 1.29. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company has a 50 day simple moving average of $143.36 and a 200 day simple moving average of $133.96. Agilent Technologies has a 1 year low of $96.43 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the firm posted $1.46 earnings per share. The company’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts anticipate that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a $0.255 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 16,401 shares of company stock valued at $2,468,962 over the last 90 days.

Institutional Trading of Agilent Technologies

A number of institutional investors have recently bought and sold shares of A. Flynn Zito Capital Management LLC raised its position in shares of Agilent Technologies by 3.2% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after acquiring an additional 69 shares in the last quarter. Forum Financial Management LP grew its stake in Agilent Technologies by 2.5% during the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after purchasing an additional 70 shares during the period. Gabelli Funds LLC increased its holdings in Agilent Technologies by 1.1% in the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after purchasing an additional 74 shares in the last quarter. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the period. Finally, NorthCrest Asset Manangement LLC lifted its stake in Agilent Technologies by 1.6% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.